|
TCP11L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.9183999923107E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.63249977372482E-10 |
| Normal-vs-Stage2 |
2.18909999999406E-05 |
| Normal-vs-Stage3 |
4.66919947150757E-10 |
| Normal-vs-Stage4 |
8.83790041150689E-10 |
| Stage1-vs-Stage2 |
6.794400E-01 |
| Stage1-vs-Stage3 |
4.173900E-02 |
| Stage1-vs-Stage4 |
4.642100E-02 |
| Stage2-vs-Stage3 |
7.086100E-02 |
| Stage2-vs-Stage4 |
7.857600E-02 |
| Stage3-vs-Stage4 |
8.165200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.98969998652399E-09 |
| Normal-vs-AfricanAmerican |
2.390400E-02 |
| Normal-vs-Asian |
2.84790000026902E-07 |
| Caucasian-vs-AfricanAmerican |
1.003160E-01 |
| Caucasian-vs-Asian |
9.130000E-01 |
| AfricanAmerican-vs-Asian |
1.424580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.5903999945065E-08 |
| Normal-vs-Female |
2.48334686148155E-12 |
| Male-vs-Female |
8.581200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.67130001347016E-09 |
| Normal-vs-Age(41-60Yrs) |
1.58869584154786E-11 |
| Normal-vs-Age(61-80Yrs) |
6.29660001916221E-09 |
| Normal-vs-Age(81-100Yrs) |
5.210500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.990400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.253000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.767420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.870400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.441000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.244600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.53518000000075E-05 |
| Classical-VS-Follicular |
1.859640E-01 |
| Classical-VS-Other |
4.607800E-01 |
| Classical-VS-Normal |
1.70169999980097E-07 |
| Tall-VS-Follicular |
1.376450E-02 |
| Tall-VS-Other |
2.506400E-01 |
| Tall-VS-Normal |
4.47064607556058E-12 |
| Follicular-VS-Other |
7.944600E-01 |
| Follicular-VS-Normal |
9.21319998070658E-09 |
| Other-VS-Normal |
6.196500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.64049926157873E-11 |
| Normal-vs-N1 |
4.02680000455291E-09 |
| N0-vs-N1 |
3.168400E-01 |
|
|
